The current status of myoblast transfer

Neurological Sciences

Volumn 21, Issue 3 SUPPL., 2000, Pages

  Partridge, T ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Duchenne muscular dystrophy; Myoblast transfer; Stem cell therapy

Indexed keywords

ANIMAL; ARTICLE; CLINICAL TRIAL; CYTOLOGY; DISEASE MODEL; DUCHENNE MUSCULAR DYSTROPHY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; METHODOLOGY; MUSCLE CELL; MUSCLE DEVELOPMENT; PATHOPHYSIOLOGY; SKELETAL MUSCLE; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; HUMANS; MUSCLE DEVELOPMENT; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE TRANSPLANTATION;

EID: 0034576937     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Le Deist F, Fischer A (2000) Gene therapy of human severe combined immunodeficiency (SCID)-Xl disease. Science 288:669-672
2. Bateson RG, Woodrow DF, Sloper JC ( 1967) Circulating cell as a source of myoblasts in regenerating injured mammalian skeletal muscle. Nature 213:1035-1036
3. Grounds M, Partridge TA, Sloper JC ( 1980) The contribution of exogenous cells to regenerating skeletal muscle: An isoenzyme study of muscle allografts in mice. J Pathol 132:325-341
4. Partridge TA, Grounds M, Sloper JC (1978) Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature 273:306-308
5. Partridge TA (1982) Cellular interactions in the development and maintenance of skeletal muscle. In: Curtis BRA, Dünn G (eds) The social abilities of cells. Cambridge University, Cambridge, pp 555-581
6. Law PK, Yap JL (1979) New muscle transplant method produces normal twitch tension in dystrophic muscle. Muscle Nerve 2:356-363
7. Law P ( 1982) Beneficial effects of transplanting normal limbbud mesenchyme into dystrophic mouse muscles. Muscle Nerve 5:619-627
8. Law PK, Goodwin TG, Li HJ (1988) Histoincompatible myoblast injection improves muscle structure and function of dystrophic mice. Transplant Proc 20:1114-1119
9. Morgan JE, Watt DJ, Sloper JC, Partridge TA (1988) Partial correction of an inherited biochemical defect of skeletal muscle by grafts of normal muscle precursor cells. J Neurol Sei 86:137-147
10. Watt DJ, Morgan JE, Partridge TA (1984) Use of mononuclear precursor cells to insert allogeneic genes into growing mouse muscles. Muscle Nerve 7:741-750
11. Huffman EP, Brown RH, Kunkel LM (1987) Dystrophin: the protein product of the Duchene muscular dystrophy locus. Biotechnology 24:457-466
12. Partridge TA, Morgan JE, Coulton GR, Huffman EP, Kunkel LM (1989) Conversion of mdx myofibres from dystrophinnegative to -positive by injection of normal myoblasts. Nature 337:176-179
13. Vilquin JT, Kinoshita I, Roy B, Goulet M, Engvall E, Tome F, Fardeau M, Tremblay JP (1996) Partial laminin a2 chain restoration in
14. Frair PM, Peterson AC (1983) The nuclear-cytoplasmic relationship in "mosaic" skeletal muscle fibres from mouse chimaeras. Exp Cell Res 145:167-178
15. Hermanson JW, Moschella MC, Ontell M (1988) Effect of neonatal denervation-reinnervation on the functional capacity of 129/ReJ dy/dy murine dystrophic muscle. J Exp Neurol 102:210-216
16. Partridge TA (1991) Invited review. Myoblast transfer: a possible therapy for inherited myopathies? Muscle Nerve 14:197-212
17. Griggs RC, Karpati G (1990) Myoblast transfer therapy. Plenum Press, New York
18. Gussoni E, Pavlath GK, Lanctot AM, Sharma KR, Miller RG, Steinman L, Blau HM (1992) Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356:435-438
19. Huard J, Roy R, Bouchard JP, Malouin F, Richards CL, Tremblay JP (1992) Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant Proc 18:3049-3051
20. Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk Z, Benson S, McAndrew PE, Rice R, Nagaraja H, Stephens R, Lantry L, Morris GE, Burghes AHM (1995) Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 333:832-838
21. Law PK, Bertorini TE, Goodwin TG, Chen M, Fang QW, Li HJ, Kirby DS, Florendo JA, Herrod HG, Golden GS (1990) Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 336:114-115
22. Law PK (1993) Myoblast transfer therapy. Lancet 341:247
23. Law PK, Goodwin TG, Fang Q, Hall TL, Quinley T, Vastagh G, Duggirala V, Larkin C, Florendo JA, Li L, Jackson T, Yoo TJ, Chase N, Neel M, Krahn T, Holcomb R (1997) First human myoblast transfer therapy continues to show dystrophin after 6 years. Cell Transplant 6:95-100
24. Huffman EP (1993) Myoblast transplantation: What's going on? Cell Transplant 2:49-57
25. Partridge TA (1996) Myoblast transplantation. In: Lanza RP, Chick WL (eds) Yearbook of cell and tissue transplantation 1996/1997. Kluwer Academic, Netherlands, pp 53-59
26. Nicholson LV, Johnson MA, Bushby KM, Gardner Medwin D (1993) Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy. Arch Dis Child 68:632-636
27. Partridge TA, Lu QL, Morris G, Huffman E (1998) Is myoblast transplantation effective? Nat Med 4:1208-1209
28. Grounds MD (1996) Commentary on the present state of knowledge for myoblast transfer therapy. Cell Transplant 5:431-433
29. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F (1997) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530
30. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC (1999) Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 410:390-394
31. Jackson KA, Mi T, Goodell MA (1999) Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sei USA 96:14482-14486
32. Pagel CN, Partridge TA (1999) Covert persistence of mdx mouse myopathy is revealed by acute and chronic effects of radiation. J Neurol Sei 164:103-116
33. Wakeford S, Watt D, Partridge T (1991) X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve 14:42-50
34. Weller B, Karpati G, Lehnert S, Carpenter S, Ajdukovic B, Holland P (1991) Inhibition of myosatellite cell proliferation by gamma irradiation does not prevent the age-related increase of the number of dystrophin-positive fibers in soleus muscles of mdx female hétérozygote mice. Am J Pathol 138:1497-1502
35. Heslop L, Morgan JE, Partridge TA (2000) Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J Cell Sei 113:2299-2308
36. Beauchamp JR, Morgan JE, Pagel CN (1994) Quantitative studies of the efficacy of myoblast transplantation. Muscle Nerve Suppl 1:S261
37. Morgan JE, Beauchamp JR, Peckham M, Ataliotis P, Jat PS, Noble MD, Farmer K, Partridge T (1994) Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: A model system for the derivation of tissue-specific and mutation-specific cell lines. Dev Biol 162:486-498
38. Qu Z, Balkir E, van Deutekom JCT, Robbins PD, Pruchnic R, Huard J (1998) Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142:1257-1267
39. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA (1999) Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 144:1113-1121
40. Morgan JE, Fletcher RM, Partridge TA (1996) Yields of normal muscle from precursor cells implanted into pre-irradiated and non-irradiated legs of young and old mdx mice. Muscle Nerve 19:132-139